跳至主要内容
临床试验/ACTRN12620000439943
ACTRN12620000439943尚未招募未知

A nurse-led clinical pathway to reduce the burden of cardiovascular disease in breast cancer patients and survivors: Phase 2 - Pilot Implementation Trial

Flinders University0 个研究点目标入组 50 人开始时间: 2020年4月6日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Key inclusion criteria are:
  • (a) adults (aged over 18 years)
  • (b) have sufficient English language ability to provide informed consent (assessed via approaching clinician upon approach)
  • (c) newly diagnosed with breast cancer or diagnosed within the past 6 months
  • (d) life expectancy of one year or more (according to the treating oncologist’s estimate)

排除标准

  • Patients will be excluded if they are assessed by the approaching clinician to have:
  • (a) clinically significant/elevated distress, or
  • (b) significant cognitive impairment that may impact ability to give informed consent or participate effectively, or
  • (c) to be too unwell to comfortably participate (e.g. end stage disease).
  • No other exclusion criteria will apply.

研究者

相似试验